This participation rate is substantially higher than that for a first screening round in this and previous Swedish population-based prostate cancer detection studies.11,14,15 The high compliance is likely due to the eligibility criteria for the second screening round (men with PSA levels ≥1.5 ng/mL participating and complying in the first round). This evidence concerns the gene KLK3 and prostate cancer.